Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States.

ABSTRACT:

Background & aims

The pandemic has resulted in an increase of deaths not directly related to COVID-19 infection. We aimed to use a national death dataset to determine the impact of the pandemic on people with liver disease in the USA, focusing on alcohol-associated liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD).

Methods

Using data from the National Vital Statistic System from the Center for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) platform and ICD-10 codes, we identified deaths associated with liver disease. We evaluated observed vs. predicted mortality for 2020-2021 based on trends from 2010-2019 with joinpoint and prediction modelling analysis.

Results

Among 626,090 chronic liver disease-relat

SUBMITTER: Gao X 

PROVIDER: S-EPMC9611810 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature